THC withdrawal reduced motivation for sucrose in mice, modeling the anhedonia of cannabis cessation | Research

The takeaway

Rimonabant-precipitated THC withdrawal significantly reduced motivation for sucrose rewards in mice, providing an animal model of the reduced motivation and pleasure that characterize human cannabis withdrawal.

Addiction researchers developing cannabis withdrawal models and testing cessation medications

Precipitated withdrawal reduced break point, response rate, and run rate vs. vehicle-treated mice

What the researchers found

Precipitated THC withdrawal (via rimonabant) caused large decreases in break point, overall response rate, and run rate on a progressive-ratio schedule in THC-treated but not vehicle-treated mice. Spontaneous withdrawal had no effect. The CB1 positive allosteric modulator ZCZ011 did not prevent the withdrawal-induced impairment.

Why it matters

Cannabis withdrawal involves subjective dysphoria (low mood, reduced motivation) that drives relapse. This model captures these subjective aspects better than traditional somatic withdrawal signs.

The numbers in context

THC 10 mg/kg for 5-6 days. Precipitated (not spontaneous) withdrawal reduced break point, response rate, and run rate in THC-treated vs. vehicle-treated mice. ZCZ011 (10 mg/kg) did not prevent impairment.

How the study worked

Male and female mice received THC (10 mg/kg) or vehicle for 5-6 days. Behavior measured on a progressive-ratio schedule of sucrose reinforcement. Withdrawal precipitated with rimonabant (2 mg/kg) or assessed spontaneously over 3 days.

What this study cannot tell us

Rimonabant-precipitated withdrawal is more severe than typical human withdrawal; spontaneous withdrawal had no effect (suggesting the model may overestimate withdrawal impact); only one CB1 PAM tested.

How to read the evidence

Single animal study with both sexes; precipitated withdrawal model may be more severe than spontaneous human withdrawal.

When this study was published

Published in 2020.

The bigger picture

Developing better animal models of the motivational aspects of cannabis withdrawal is essential for testing potential cessation medications that restore normal functioning rather than just suppressing physical symptoms.

Questions still open

Would other pharmacological approaches restore motivation during withdrawal? Does the lack of spontaneous withdrawal effect limit the model's clinical relevance?

Common questions

What is anhedonia in cannabis withdrawal?

Anhedonia is reduced ability to experience pleasure. During cannabis withdrawal, people often report low mood, lack of motivation, and decreased enjoyment of activities they normally find rewarding. This study modeled these symptoms using reduced motivation for sucrose in mice.

Could this help develop withdrawal medications?

Yes. This progressive-ratio model captures the motivational deficits of withdrawal and can test whether potential medications restore normal motivation, which is more clinically relevant than just measuring physical withdrawal signs.

Read the original research

Precipitated Δ9-THC withdrawal reduces motivation for sucrose reinforcement in mice.

Pharmacology, biochemistry, and behavior, 195, 172966

View on PubMed ↗Publisher’s paper ↗

Citation

Eckard, M L; Trexler, K R; Kotson, B T; Anderson, K G; Kinsey, S G. (2020). Precipitated Δ9-THC withdrawal reduces motivation for sucrose reinforcement in mice.. Pharmacology, biochemistry, and behavior, 195, 172966. https://doi.org/10.1016/j.pbb.2020.172966